Oral Cancer News – Page 56 – The Oral Cancer Foundation News Archive

Flossing and going to the dentist linked to lower risk of oral cancer

Source: www.livescience.com Author: Yasemin Saplakoglu, Staff Writer Regularly flossing and going to the dentist may be tied to a lower risk of oral cancer. That's according to findings presented March 31, here at the American Association for Cancer Research (AACR) annual meeting. In the new study, researchers analyzed the dental health behaviors of patients who were diagnosed with oral cancer between 2011 and 2014 at the ear, nose and throat clinic at The Ohio State University Comprehensive Cancer Center. The patients' behaviors were compared to those of non-cancer patients who came to the clinic for other reasons, such as dizziness or an earache. [7 Odd Things That Raise Your Risk of Cancer (and 1 That Doesn't)] All of the patients in the study had responded to a survey that included questions about how often they flossed, how often they went to the dentist, how sexually active they were and if they smoked or drank alcohol. Oral cancer can be divided into two categories: those driven by the sexually transmitted human papillomavirus (HPV) and those that aren't, said lead study author Jitesh Shewale, a postdoctoral fellow at the University of Texas MD Anderson Cancer Center in Houston. (Smoking and drinking are both risk factors for non-HPV oral cancers.) After adjusting for factors such as age, gender, socioeconomic status and race, the researchers found that oral HPV-negative people who went to the dentist less than once a year had nearly twice the risk of developing oral cancer than those who went once [...]

Oral Cancer Foundation News Team - A2019-04-02T11:40:32-07:00April, 2019|Oral Cancer News|

How do speech-language pathologists support cancer patients?

Source: syvnews.com Author: Aundie Werner Question: What are speech-language pathologists and how do they support cancer patients? It is estimated that about 100,000 people will be diagnosed with a head, neck or thyroid cancer this year. Although this does not grab headlines as often as many other cancers, for those affected the disease and treatment can have a significant impact on their lives. In general, most people survive head and neck cancer; however, side effects of treatment can sometimes be a long-term problem. The support and guidance of a speech-language pathologist (SLP) can do much to help promote recovery and cope with the difficult symptoms of treatment. Ideally, the SLP becomes involved when the patient has been identified as having head and neck cancer before their surgery or before their chemotherapy/radiation protocol. Counseling and education are provided as to the functions of voice, speech and swallowing. Assessment is made to determine the patient’s baseline and to provide guidance as to the patient’s role in their rehabilitation. Frequently, the SLP works with patients who have difficulty eating and drinking. Treatment is based on the cause of the problem: anatomical changes from surgery, decreased saliva, changes in taste, difficulty opening the mouth due to trismus, and problems protecting the airway, which can result in coughing and choking during meals. Maintaining nutrition after surgery and during treatment is necessary to help the body heal. At times, the patient may need to have a feeding tube to help with nutrition when it becomes too [...]

Oral Cancer Foundation News Team - A2019-03-26T11:50:47-07:00March, 2019|Oral Cancer News|

Robot that can cut out hard-to-reach throat tumours through patients’ mouths: Pioneering operation reduces need for chemo and radiotherapy

Source: www.dailymail.co.uk Author: Fiona McCrae, Roger Dobson British surgeons are using a cutting-edge robot to remove difficult-to-reach throat tumours – through the mouths of patients. The pioneering operation is designed to dramatically reduce the need for gruelling radiotherapy and chemotherapy, which can leave patients unable to swallow and dependent on a feeding tube for life. With growing numbers of people developing throat cancer, it is more important than ever to have a range of effective treatments that lessen the impact on quality of life, says Asit Arora, consultant head and neck surgeon at Guy’s & St Thomas’ NHS Trust in London. Once most common in elderly people with a history of drinking and smoking, rates of head and neck cancers have soared by 31 per cent in the past 25 years and are now as common in people in their 50s as in those in their 80s. The 90 minute operation is designed to dramatically reduce the need for gruelling radiotherapy and chemotherapy, which can leave patients unable to swallow and dependent on a feeding tube for life Much of the rise is attributed to HPV – a range of viruses that can be passed on during intimate and sexual contact. At least 80 per cent of the adult population carries some kinds of HPV on their skin, although most will never know it. In some cases, HPV can cause skin or genital warts, and other types are a known cause of cervical and anal cancers. HPV can [...]

Oral Cancer Foundation News Team - A2019-03-11T13:59:53-07:00March, 2019|Oral Cancer News|

HPV infection may be behind rise in vocal-cord cancers among young nonsmokers

Source: www.eurekalert.org Author: Public Release Massachusetts General Hospital A remarkable recent increase in the diagnosis of vocal-cord cancer in young adults appears to be the result of infection with strains of human papilloma virus (HPV) that also cause cervical cancer and other malignancies. Investigators from Massachusetts General Hospital (MGH) describe finding HPV infection in all tested samples of vocal-cord cancer from 10 patients diagnosed at age 30 or under, most of whom were non-smokers. Their report appears in a special supplement on innovations in laryngeal surgery that accompanies the March 2019 issue of Annals of Otology, Rhinology and Laryngology. "Over the past 150 years, vocal-cord or glottic cancer has been almost exclusively a disease associated with smoking and almost entirely seen in patients over 40 years old," says Steven Zeitels, MD, director of the MGH Division of Laryngeal Surgery, senior author of the report. "Today nonsmokers are approaching 50 percent of glottic cancer patients, and it is common for them to be diagnosed under the age of 40. This epidemiologic transformation of vocal-cord cancer is a significant public health issue, due to the diagnostic confusion it can create." The researchers note that the increase in vocal-cord cancer diagnosis appears to mimic an earlier increase in the diagnosis of throat cancer, which has been associated with infections by high-risk strains of HPV. After initially attributing incidents of vocal-cord cancer in nonsmokers, which they began to see about 15 years ago, to increased travel and exposure to infectious diseases, Zeitels and his [...]

Oral Cancer Foundation News Team - A2019-03-06T15:08:22-07:00March, 2019|Oral Cancer News|

Suspect laryngeal cancer in patients with sore throat and hoarseness, GPs urged

Source: www.pulsetoday.co.uk Author: Isobel Sims GPs should suspect laryngeal cancer and consider urgent referral in patients who present with a persistent sore throat and hoarseness, according to a new study. A recurrent sore throat in combination with symptoms such as hoarseness, difficulty swallowing or ear pain increases the likelihood that a patient has laryngeal cancer and may warrant urgent referral, the authors said. The study, published in the British Journal of General Practice, was carried out by researchers at the University of Exeter and looked at primary care data for just over 800 patients diagnosed with laryngeal cancer, as well as just over 3,500 controls. The researchers found hoarseness carried the greatest individual risk, with those presenting with the symptom having a 2.7% likelihood of having laryngeal cancer – just under the NICE (National Institue for Health & Care Excellene) threshold of 3% for urgent referral. Patients presenting with a recurrent sore throat in combination with hoarseness had a 12% likelihood of having laryngeal cancer. The likelihood of cancer was also increased above the NICE threshold when recurrent sore throat presented with dysphagia, recurrent dyspnoea, ear pain and raised inflammatory markers, the researchers said. They found that, ‘unexpectedly’, neck lumps were not associated with laryngeal cancer. The authors said the findings back up the NICE recommendation to consider referring patients with persistent unexplained hoarseness, but that GPs should also be vigilant about symptoms not currently listed in the NICE guidance. The paper said: ‘This evidence supports some of the recommendations [...]

Oral Cancer Foundation News Team - A2019-03-06T15:03:59-07:00March, 2019|Oral Cancer News|

How regular use of painkillers could boost survival rates from cancer

Source: www.mirror.co.uk Author: Miriam Stoppard In recent research, aspirin or ibuprofen were found to treble the chance of beating head and neck cancer. Could regular use of aspirin or ibuprofen boost survival rates from head and neck cancer? It seems it’s possible. In recent research, the common painkillers were found to treble the chance of survival (from 25% to 78%) for patients with a specific kind of cancer which contains an altered gene, known as PIK3CA. Around a third of head and neck cancers carry this mutation and it’s also found in other types of cancer. Head and neck cancer is newly diagnosed in more than 12,000 people in the UK each year, and in 65,000 in the US. It kills just over 4,000 people here and 14,000 in America. There are more than 30 areas in the head and neck where cancer can develop, such as the mouth and throat. Researchers at the University of California, San Francisco, looked at five-year survival rates for people diagnosed with the disease and found the regular use of non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, significantly improved survival for a third or more of patients with the disease. All the patients had the mutated gene. NSAIDs, however, had no effect on tumours without PIK3CA mutation. The study included 266 patients from the University of Pittsburgh Medical Center whose tumours were surgically removed. Altogether, 75 tumours (28%) in the study had a change in the PIK3CA gene. Among the patients who [...]

Oral Cancer Foundation News Team - A2019-03-06T10:00:16-07:00March, 2019|Oral Cancer News|

Woman gets new tongue made from her arm after cancer battle

Source: www.mirror.co.uk Author: Laura Elvin A woman who lost her tongue while fighting cancer has had a new one made from her arm. Despite being a non-smoker Joanna Smith, 58, was diagnosed with tongue cancer after she found a tiny 'ulcer' in her mouth. The grandmother-of-four was given eight months to live unless she had it removed, so went through with a 15-hour surgery. Doctors removed her tongue via a hole in her neck and made a new one using skin, muscle and a long vein from her left arm . The cleaner, from Bedfordshire, was able to talk as soon as she woke up and can now eat and drink on her own. However, she has no taste buds on the new organ and has to eat slowly to avoid biting it - but is cancer free and expected to make a full recovery. The mum-of-two said: "It's a bit weird. I look at my arm and I can see where my tongue has come from. "I think 'that's in my mouth now but yet I can talk' and that's really weird. I can't stick my tongue out and I can't say it really feels like a tongue. It feels a bit surreal. Before I had it done I was thinking to myself 'how it that going to work' but now I've had it I'm like 'wow'." "It's really weird but it shows what they can do now." Joanna noticed a tiny dot on the side of her tongue [...]

Oral Cancer Foundation News Team - A2019-02-19T07:27:18-07:00February, 2019|Oral Cancer News|

E-cig users develop some of the same cancer-related molecular changes as cigarette smokers

Source: EurekAlert! Date: February 14, 2019 If you think vaping is benign, think again. A small USC study shows that e-cig users develop some of the same cancer-related molecular changes in oral tissue as cigarette smokers, adding to the growing concern that e-cigs aren't a harmless alternative to smoking. The research, published this week in the International Journal of Molecular Sciences, comes amid a mushrooming e-cig market and mounting public health worries. On a positive note, recent research found vaping is almost twice as effective as other nicotine replacement therapies in helping smokers quit. But among adolescents, vaping now surpasses smoking, and there's evidence that e-cig use leads to nicotine addiction and future smoking in teens. "The existing data show that e-cig vapor is not merely 'water vapor' as some people believe," said Ahmad Besaratinia, an associate professor at Keck School of Medicine of USC and the study's senior author. "Although the concentrations of most carcinogenic compounds in e-cig products are much lower than those in cigarette smoke, there is no safe level of exposure to carcinogens." Besaratinia emphasized that the molecular changes seen in the study aren't cancer, or even pre-cancer, but rather an early warning of a process that could potentially lead to cancer if unchecked. The researchers looked at gene expression in oral cells collected from 42 e-cig users, 24 cigarette smokers and 27 people who didn't smoke or vape. Gene expression is the process by which instructions in our DNA are converted into a functional product, [...]

Charlotte Parker2019-02-18T10:40:06-07:00February, 2019|Oral Cancer News|

Pioneering surgery to regrow woman’s jaw hailed a ‘success’

Source: www.breakingnews.ie Author: staff A pioneering operation to regrow a woman’s jaw from her own skin and bone after she lost it from cancer has been branded a “significant success”. Val had her entire lower jaw removed including her glands, chin, lower lip and part of her tongue after being diagnosed with cancer in 2015, leaving her unable to eat, drink or talk. The 55-year-old from Wolverhampton eventually under went a pioneering surgical technique – known as distraction osteogenesis – to encourage her jaw to grow back after two previous attempts to reconstruct it failed. This involved surgeons at trust’s maxillofacial service at Nottingham University Hospitals NHS Trust’s Queen’s Medical Centre (QMC) fitting her with a facial frame to act as “scaffolding” around which her own bone and tissue can grow back. Val has had two further operations including one last month to remove the frame, and was discharged on Thursday. Doctors said 90mm of bone had grown since the operation in January 2018 – and branded the procedure a “significant success”. Val after the pioneering operation to regrow her jaw (Nottingham University Hospital) Val said it had been a “leap of faith” to undergo the surgery – which was the first time it had been carried out in the UK. She added: “Just over a year ago I was resigned to the fact I would have to wear a prosthetic chin for the rest of my life, but after one of our brainstorming sessions at my local [...]

Oral Cancer Foundation News Team - A2019-02-15T14:21:45-07:00February, 2019|Oral Cancer News|

Scientists to test light therapy as relief from side effects of cancer treatment

Source: www.photonics.com Author: staff University at Buffalo (UB) researchers have received part of a $1.5 million grant to investigate light therapy as a replacement for prescription opioids in treating oral mucositis, painful ulcers, and swelling in the mouth that result from chemotherapy and radiation treatment for cancer. Funded by the National Institutes of Dental and Craniofacial Research Small Business Innovation Research program, the grant will help the researchers determine the effectiveness of photobiomodulation in prevention and treatment of oral mucositis after cancer treatment. At a high power, light, often in the form of a laser, is used in medicine to cut or destroy tissue. But at a low level, it has the ability to relieve pain and promote healing. Courtesy of Douglas Levere, University at Buffalo The grant was awarded to Cleveland-based MuReva Phototherapy, a spin-off company of lighting solutions manufacturer Lumitex, to further develop the light technology. UB received $511,000 of the award to test the technology. The research, led by Praveen Arany, DDS, assistant professor in the UB School of Dental Medicine, will be performed in collaboration with faculty from the Departments of Radiation Medicine and Oral Oncology at Roswell Park Comprehensive Cancer Center. “The current epidemic of opioids has impacted cancer care, especially for cancer pain relief,” Arany said. “This treatment offers a simple, nondrug, noninvasive treatment approach to relieve pain and improve quality of life for cancer patients. The striking lab and clinical evidence for photobiomodulation treatments in supportive cancer care has demonstrated tremendous [...]

Oral Cancer Foundation News Team - A2019-02-15T14:14:51-07:00February, 2019|Oral Cancer News|